Portfolio concentration
As of April 30, 2026 · N-PORT
Holdings
33
Top-10 weight
58.96%
Effective holdings
?
The number of equal-weight positions that would produce this portfolio's concentration (1 ÷ Herfindahl index). A 500-stock fund dominated by a few mega-caps might have only ~100 effective holdings.
20
Crowding
?
The value-weighted average number of funds that also own this fund's positions. High = consensus/crowded picks; low = holdings few other funds own.
297.4
Holdings
As of April 30, 2026 · N-PORT| # | Security | Ticker | Shares | Value | % of fund |
|---|---|---|---|---|---|
| 1 | TEMPUS AI INC-A | — | 2,098,455 | $116.42M | 9.42% |
| 2 | TWIST BIOSCIENCE CORP | — | 1,900,539 | $111.09M | 8.99% |
| 3 | CRISPR THERAPEUTICS AG | — | 2,103,707 | $110.11M | 8.91% |
| 4 | 10X GENOMICS INC | — | 3,232,541 | $71.28M | 5.77% |
| 5 | BEAM THERAPEUTICS INC | — | 2,212,153 | $67.09M | 5.43% |
| 6 | ABSCI CORP | — | 11,876,202 | $59.08M | 4.78% |
| 7 | NATERA INC | — | 243,718 | $50.24M | 4.07% |
| 8 | ILLUMINA INC | — | 392,835 | $49.79M | 4.03% |
| 9 | INTELLIA THERAPEUTICS INC | — | 3,498,399 | $47.16M | 3.82% |
| 10 | PERSONALIS INC | — | 8,017,242 | $44.26M | 3.58% |
| 11 | RECURSION PHARMACEUTICALS INC | — | 12,549,240 | $43.42M | 3.51% |
| 12 | GUARDANT HEALTH INC | — | 496,000 | $43.19M | 3.49% |
| 13 | CAREDX INC | — | 2,009,757 | $41.82M | 3.38% |
| 14 | VERACYTE INC | — | 999,975 | $32.92M | 2.66% |
| 15 | COMPASS Pathways PLC, ADR | CMPS | 3,316,076 | $30.04M | 2.43% |
| 16 | ADAPTIVE BIOTECHNOLOGIES CORP | — | 2,123,561 | $29.94M | 2.42% |
| 17 | NURIX THERAPEUTICS INC | — | 1,723,734 | $28.79M | 2.33% |
| 18 | GENEDX HOLDINGS CORP-A | — | 401,292 | $25.24M | 2.04% |
| 19 | SCHRODINGER INC | — | 2,093,199 | $25.03M | 2.03% |
| 20 | ARCTURUS THERAPEUTICS HOLDINGS INC | — | 2,809,043 | $24.21M | 1.96% |
| 21 | BUTTERFLY NETWORK INC A | — | 4,889,029 | $23.42M | 1.89% |
| 22 | IONIS PHARMACEUTICALS INC | — | 288,230 | $21.55M | 1.74% |
| 23 | ATAIBECKLEY INC | — | 4,382,604 | $18.23M | 1.48% |
| 24 | PRIME MEDICINE INC | — | 4,925,864 | $17.46M | 1.41% |
| 25 | PACIFIC BIOSCIENES OF CALI INC | — | 10,964,895 | $17.43M | 1.41% |
| 26 | CERUS CORP | — | 7,450,534 | $15.12M | 1.22% |
| 27 | Alamar Biosciences, Inc. | — | 596,585 | $14.94M | 1.21% |
| 28 | 908 DEVICES INC | — | 1,952,552 | $13.34M | 1.08% |
| 29 | BIONTECH SE ADR | — | 126,929 | $13.13M | 1.06% |
| 30 | LILLY ELI and CO | — | 12,571 | $11.75M | 0.95% |
| 31 | QUANTUM-SI INC | — | 6,928,343 | $6.79M | 0.55% |
| 32 | GENERATE BIOMEDI | — | 503,531 | $6.36M | 0.51% |
| 33 | Goldman Sachs Financial Square Treasury Obligations Fund | — | 1,581,573 | $1.58M | 0.13% |
Machine-readable: JSON · Markdown. Programmatic access via the agent surface.